RIVER PALM, MAHWAH, NEW JERSEY
HIGH RISK PCI AND CARDIOGENIC SHOCK: THE ROLE OF HEMODYNAMIC SUPPORT
AJAY J. KITANE, MD, SM, FACC, FSCAI
Chief Academic Officer, Center for Interventional Vascular Therapy
Associate Professor of medicine at Columbia University Medical Center
Director, Interventional Cardiology Fellowship Program and Cath Lab Quality
New York-Presbyterian Hospital
- A Randomized Clinical Trial to Evaluate the Safety and Efficacy of a Percutaneous Left Ventricular Assist Device Versus Intra-Aortic Balloon Pumping for Treatment of Cardiogenic Shock Caused by Myocardial Infarction
- A Prospective, Randomized Clinical Trial of Hemodynamic Support With Impella 2.5 Versus Intra-Aortic Balloon Pump in Patients Undergoing High-Risk Percutaneous Coronary Intervention: The PROTECT II Study
- Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic Shock
- A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines?
- The outcome of intra-aortic balloon pump support in acute myocardial infarction complicated by cardiogenic shock according to the type of revascularization: A comprehensive meta-analysis
- Percutaneous Left-Ventricular Support With the Impella-2.5-Assist Device in Acute Cardiogenic Shock: Results of the Impella-EUROSHOCK-Registry
- The Impella 2.5 and 5.0 devices for ST-elevation myocardial infarction patients presenting with severe and profound cardiogenic shock: The Academic Medical Center intensive care unit experience*
- The Ability to Achieve Complete Revascularization Is Associated with Improved In--hospital Survival in Cardiogenic Shock due to Myocardial Infarction: Manitoba Cardiogenic Shock Registry Investigators
- The Current Use of Impella 2.5 in Acute Myocardial Infarction Complicated by Cardiogenic Shock: Results from the USpella Registry
ObjectivesFollowing the completion of this program, participants should be able to:
1. Discuss the most recent cardiac research and clinical information in order to maintain a
leading edge in clinical competency.
2. Identify the most current trends in the diagnosis and treatment of cardiac disease.
3. Promote discussion regarding the valve of information being presented.
Good Samaritan Hospital Accredited by the Medical Society of the State of New York (MSSNY) to provide Continuing Medical Education for physicians.
Good Samaritan Hospital designates this Journal-Based CME activity for a Maximum of two credits AMA/PRA Category One Credit Physicians should only claim the credit commensurate with the extent of their participation in the activity.
Facility Disclosure Statement
All faculties participating in continuing medical education programs sponsored by Good Samaritan Hospital are expected to disclose to the program audience any real or apparent conflict(s) of interest related to the content of their presentation.
Underwritten by an unrestricted grant from